What is LeMaitre Vascular's market cap?

LeMaitre Vascular (LMAT) has a market capitalization of $2.3B and trades on NASDAQ.

What is LeMaitre Vascular's revenue and profitability?

LeMaitre Vascular generated $256.3M in trailing twelve-month revenue with net income of $62.4M, representing a net margin of 24.3%. Gross margin stands at 72.4%, with free cash flow of $79.1M. These figures are based on the Q1 2026 filing.

Who are LeMaitre Vascular's competitors?

LeMaitre Vascular's key competitors include Artivion, Medtronic, Merit Medical Systems Inc, and others. These companies compete in similar markets and product categories.

Who does LeMaitre Vascular partner with?

LeMaitre Vascular's notable partners include Elutia Inc., Andramed GmbH, Emergo Group.

What subsidiaries does LeMaitre Vascular have?

LeMaitre Vascular's subsidiaries include RestoreFlow, Artegraft.

Where is LeMaitre Vascular headquartered?

LeMaitre Vascular is headquartered in United States of America and employs approximately 630 people. It has been publicly traded since 2006.

LeMaitre Vascular

LMAT

Market cap

$2.26B+22.1%

Revenue$256.3M+13.3%

Net income$62.4M+38.2%

Free cash flow$79.1M+92.4%

EPS (diluted)$2.71+37.6%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 5, 2026

Revenue$66.6MMiss by $122.6K EPS$0.68Beat by $0.02

Read the full report

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$71.5M

EPS estimate$0.81

Financials

Q1 2026

Income statement

See full

Revenue$66.6M+11.2%

Gross profit$48.4M+16.8%

Operating income$17.8M+40.8%

Net income$15.7M+42.4%

EPS (diluted)$0.68+41.7%

Balance sheet

See full

Cash & equivalents$26.9M+6.0%

Total debt$20.9M+20.6%

Total equity$406.6M+17.0%

Total assets$629.5M+13.2%

Cash flow

See full

Operating cash flow$15.1M+67.0%

CapEx$2.8M+101%

Free cash flow$12.3M+60.8%

Valuation & ratios

Valuation

See full

Market cap$2.26B+22.1%

Enterprise value$2.25B+21.6%

P/E36.2×-3.3×

P/S8.8×+0.9×

Profitability

See full

Gross margin72.4%+3.6pp

Operating margin28.5%+5.1pp

Net margin24.3%+4.4pp

FCF margin30.9%+12.7pp

Returns & leverage

See full

Return on equity16.5%+2.8pp

Debt / equity0.1×0.0×

Current ratio14.3×-2.2×

Competitors

By market cap

Abbott$182.00B-17.2%

Medtronic$107.81B-8.5%

Edwards Lifesciences$47.8B+3.8%

Becton, Dickinson and Company$43.8B-16.5%

Baxter International$12.1B-17.6%

Merit Medical Systems$4.5B-9.1%

LeMaitre Vascular$2.3B+21.3%

Artivion$1.3B-14.0%

By revenue growth

Artivion+17.6%

Edwards Lifesciences+14.5%

LeMaitre Vascular+13.3%

Merit Medical Systems+11.1%

Medtronic+8.4%

Abbott+8.1%

Becton, Dickinson and Company+6.4%

Baxter International+5.1%

By net margin

LeMaitre Vascular24.35%+4.4pp

Edwards Lifesciences15.43%-57.5pp

Medtronic13.2%-0.7pp

Abbott11.65%-20.8pp

Merit Medical Systems9.03%+0.2pp

Becton, Dickinson and Company5.33%-2.1pp

Artivion2.55%+8.0pp

Baxter International-9.7%-4.5pp

Profile

LeMaitre is a global medical technology company specializing in the development, manufacturing, and marketing of devices and human tissue cryopreservation services for the treatment of peripheral vascular, end-stage renal, and cardiovascular diseases. The company primarily serves vascular surgeons through a niche-focused strategy, targeting low-rivalry market segments with high-quality, branded products. Its business model emphasizes a direct sales force and a robust acquisition strategy to expand its portfolio of surgical tools and biologic implants.

Competitive position

LeMaitre maintains a leading position in niche, low-rivalry vascular surgery segments by focusing on specialized tools for open surgical procedures rather than high-competition endovascular markets.

GeographiesUnited States, Europe, Canada, Asia Pacific

Customer segmentsVascular Surgeons, Cardiac Surgeons, Hospitals, Specialty Clinics

Business modelManufacturing, Direct-to-Hospital Sales, Service-based (Cryopreservation)

SuppliersTissue Procurement Organizations, Raw Material Suppliers (Polyester, ePTFE, Latex), Sterilization Service Providers, Contract Manufacturers (Andramed GmbH)

CustomersHospitals, Surgical Centers, Independent Medical Distributors

CountryUnited States of America

Listed2006

Employees630.0

CEOGeorge W. LeMaitre

SectorHealthcare

IndustryMedical - Instruments & Supplies

Websitelemaitre.com

FilingsSEC EDGAR

Ask your AI about LeMaitre Vascular.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LeMaitre Vascular's market cap?: LeMaitre Vascular (LMAT) has a market capitalization of $2.3B and trades on NASDAQ.
What is LeMaitre Vascular's revenue and profitability?: LeMaitre Vascular generated $256.3M in trailing twelve-month revenue with net income of $62.4M, representing a net margin of 24.3%. Gross margin stands at 72.4%, with free cash flow of $79.1M. These figures are based on the Q1 2026 filing.
Who are LeMaitre Vascular's competitors?: LeMaitre Vascular's key competitors include Artivion, Medtronic, Merit Medical Systems Inc, and others. These companies compete in similar markets and product categories.
Who does LeMaitre Vascular partner with?: LeMaitre Vascular's notable partners include Elutia Inc., Andramed GmbH, Emergo Group.
What subsidiaries does LeMaitre Vascular have?: LeMaitre Vascular's subsidiaries include RestoreFlow, Artegraft.
Where is LeMaitre Vascular headquartered?: LeMaitre Vascular is headquartered in United States of America and employs approximately 630 people. It has been publicly traded since 2006.